|
2025-03-14 |
2025-03-13 |
V
Vente
|
Zinda, Michael
Senior Officer of Issuer
Dirigeant
|
5 611
-10.3%
1,14
6 397 USD
|
5 611
-10.3%
|
1,14
|
6 397 USD
|
|
|
2025-03-14 |
2025-03-13 |
V
Vente
|
SEGAL, Lloyd M.
Senior Officer of Issuer
Dirigeant
|
21 179
-32.2%
1,14
24 144 USD
|
21 179
-32.2%
|
1,14
|
24 144 USD
|
|
|
2025-03-14 |
2025-03-13 |
V
Vente
|
Koehler, Maria
Senior Officer of Issuer
Dirigeant
|
3 596
-1.7%
1,14
4 099 USD
|
3 596
-1.7%
|
1,14
|
4 099 USD
|
|
|
2025-03-14 |
2025-03-13 |
V
Vente
|
Herman, Philip
Senior Officer of Issuer
Dirigeant
|
3 799
-25.9%
1,14
4 331 USD
|
3 799
-25.9%
|
1,14
|
4 331 USD
|
|
|
2025-03-14 |
2025-03-13 |
V
Vente
|
Bélanger, Daniel
Senior Officer of Issuer
Dirigeant
|
1 787
-21.2%
1,14
2 037 USD
|
1 787
-21.2%
|
1,14
|
2 037 USD
|
|
|
2025-03-14 |
2025-03-12 |
V
Vente
|
Segal Lloyd Mitchell
PRESIDENT AND CEO
Administrateur exécutif
|
21 179
-14.5%
1,14
24 144 USD
|
21 179
-14.5%
|
1,14
|
24 144 USD
|
|
|
2025-03-14 |
2025-03-12 |
V
Vente
|
Forte Steve
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
6 884
-11.2%
1,14
7 848 USD
|
6 884
-11.2%
|
1,14
|
7 848 USD
|
|
|
2025-03-14 |
2025-03-12 |
V
Vente
|
Koehler Maria
EVP, CHIEF MEDICAL OFFICER
Dirigeant
|
3 596
-1.6%
1,14
4 099 USD
|
3 596
-1.6%
|
1,14
|
4 099 USD
|
|
|
2025-03-14 |
2025-03-12 |
V
Vente
|
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Dirigeant
|
5 611
-6.5%
1,14
6 397 USD
|
5 611
-6.5%
|
1,14
|
6 397 USD
|
|
|
2025-03-07 |
2025-02-15 |
AP
Achat planifié
|
SEGAL, Lloyd M.
Senior Officer of Issuer
Dirigeant
|
2 000
+8.2%
1,08
2 160 USD
|
2 000
+8.2%
|
1,08
|
2 160 USD
|
|
|
2025-03-07 |
2025-02-15 |
AP
Achat planifié
|
Forte, Steve
Senior Officer of Issuer
Dirigeant
|
2 000
+13.1%
1,08
2 160 USD
|
2 000
+13.1%
|
1,08
|
2 160 USD
|
|
|
2025-03-07 |
2025-02-15 |
AP
Achat planifié
|
Black, Cameron
Senior Officer of Issuer
Dirigeant
|
2 000
+7.4%
1,08
2 160 USD
|
2 000
+7.4%
|
1,08
|
2 160 USD
|
|
|
2025-03-07 |
2024-08-15 |
AP
Achat planifié
|
SEGAL, Lloyd M.
Senior Officer of Issuer
Dirigeant
|
895
+3.8%
2,55
2 282 USD
|
895
+3.8%
|
2,55
|
2 282 USD
|
|
|
2025-03-07 |
2024-08-15 |
AP
Achat planifié
|
Forte, Steve
Senior Officer of Issuer
Dirigeant
|
895
+6.2%
2,55
2 282 USD
|
895
+6.2%
|
2,55
|
2 282 USD
|
|
|
2025-03-07 |
2024-08-15 |
AP
Achat planifié
|
Black, Cameron
Senior Officer of Issuer
Dirigeant
|
1 268
+5.0%
2,55
3 233 USD
|
1 268
+5.0%
|
2,55
|
3 233 USD
|
|
|
2024-04-01 |
2024-04-01 |
VP
Vente planifiée
|
Segal Lloyd Mitchell
PRESIDENT AND CEO
Administrateur exécutif
|
2 491
-2.3%
4,63
11 533 USD
|
2 491
-2.3%
|
4,63
|
11 533 USD
|
|
|
2024-04-01 |
2024-04-01 |
VP
Vente planifiée
|
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Dirigeant
|
410
-0.6%
4,66
1 911 USD
|
410
-0.6%
|
4,66
|
1 911 USD
|
|
|
2024-04-01 |
2024-04-01 |
VP
Vente planifiée
|
Forte Steve
EVP, CHIEF FINANCIAL OFFICER
Dirigeant
|
789
-1.7%
4,61
3 637 USD
|
789
-1.7%
|
4,61
|
3 637 USD
|
|
|
2024-04-01 |
2024-04-01 |
VP
Vente planifiée
|
Koehler Maria
EVP, CHIEF MEDICAL OFFICER
Dirigeant
|
300
-0.1%
4,66
1 398 USD
|
300
-0.1%
|
4,66
|
1 398 USD
|
|
|
2024-04-01 |
2024-03-28 |
VP
Vente planifiée
|
Segal Lloyd Mitchell
PRESIDENT AND CEO
Administrateur exécutif
|
2 650
-2.4%
4,62
12 243 USD
|
2 650
-2.4%
|
4,62
|
12 243 USD
|
|
